한국증권금융

한국증권금융 appears in our data through filings on 바이오플러스 shares, published by DART (FSS). We count 3 filings; the first trade dates from 28 June 2024 and the latest from 2 December 2025.

The open-market side counts 1 purchase alongside 2 sales. The totals do not cover 3 filings with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2026, the count stands at no purchases and 1 sale.

Most recently, on 8 January 2026, the filings show an open-market sale in 바이오플러스. The clock since the last published purchase (10 July 2024) now reads 851 days. Between a trade and the moment it shows up on DART (FSS), the median delay is 37 days. This delay matters because a trade only becomes useful information once it is public. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.